ECG Telemetry Devices Market Size and Share
Market Overview
| Study Period | 2021 - 2030 |
|---|---|
| Market Size (2025) | USD 6.55 Billion |
| Market Size (2030) | USD 8.92 Billion |
| Growth Rate (2025 - 2030) | 6.37% CAGR |
| Fastest Growing Market | Asia Pacific |
| Largest Market | North America |
| Market Concentration | Medium |
Major Players
*Disclaimer: Major Players sorted in no particular order Image © Mordor Intelligence. Reuse requires attribution under CC BY 4.0. |
|
ECG Telemetry Devices Market Analysis by Mordor Intelligence
The ECG telemetry devices market size reached USD 6.55 billion in 2025 and is projected to climb to USD 8.92 billion by 2030 at a 6.37% CAGR. Robust reimbursement expansion, rapid AI adoption, and miniaturized patch innovations are steering demand, while stricter cybersecurity rules and elevated component costs temper growth momentum. Device makers focus on real-time analytics, ultra-low-power design, and integrated data platforms to secure competitive advantage. Consolidation through acquisitions and partnerships, especially around advanced arrhythmia analytics, continues to reshape the landscape. Regulatory alignment across major markets accelerates global rollout of continuous-monitoring solutions, opening fresh revenue streams for service-based business models.
Key Report Takeaways
- By product type, Holter monitors led with 34.78% of the ECG telemetry devices market share in 2024, Mobile cardiac telemetry is forecast to register the highest 6.89% CAGR through 2030
- By lead type, single-lead devices accounted for 41.56% share of the ECG telemetry devices market size in 2024, 12-lead systems are projected to expand at a 7.12% CAGR between 2025-2030.
- By end user, hospitals & clinics commanded 46.89% of the ECG telemetry devices market share in 2024, Diagnostic centers are expected to post the fastest 7.45% CAGR through 2030.
- By geography, North America captured 44.23% revenue share in 2024, while Asia-Pacific is advancing at a 7.32% CAGR to 2030.
Global ECG Telemetry Devices Market Trends and Insights
Driver Impact Analysis
| Driver | (~) % Impact on CAGR Forecast | Geographic Relevance | Impact Timeline |
|---|---|---|---|
| Growing CVD prevalence & aging population | +2.1% | Global, with highest impact in North America & Europe | Long term (≥ 4 years) |
| Shift toward home & remote patient monitoring | +1.8% | Global, accelerated adoption in developed markets | Medium term (2-4 years) |
| Miniaturisation & wearable-patch innovations | +1.2% | Global, with R&D concentration in North America & Asia-Pacific | Medium term (2-4 years) |
| Reimbursement expansions for RPM services | +1.0% | North America & Europe leading, expanding to other regions | Short term (≤ 2 years) |
| AI-enabled arrhythmia analytics adoption (under-reported) | +0.9% | North America & Europe leading, expanding to Asia-Pacific | Long term (≥ 4 years) |
| Near-shoring of electronics supply chains post-tariff hikes (under-reported) | +0.7% | Global, with primary impact in North America manufacturing | Medium term (2-4 years) |
| Source: Mordor Intelligence | |||
Growing CVD Prevalence & Aging Population
Global cardiovascular disease continues rising, and older adults now seek longer monitoring periods that standard 24-48 hour studies cannot fulfill. Continuous telemetry detects more arrhythmias, as evidenced by iRhythm’s real-world data showing superior identification rates over Holter modalities Health systems connect the technology to value-based care goals by reducing readmissions and enabling early intervention. Medicare and many private payers broadened coverage, and Rural Health Clinics gained RPM billing eligibility in 2025, further stabilizing demand[1]Source: Centers for Medicare & Medicaid Services, “2025 Physician Fee Schedule Final Rule,” HFMA.org .
Shift Toward Home & Remote Patient Monitoring
Telehealth adoption matured beyond the pandemic surge once enhanced CPT codes (99453-99458) took effect in 2025, providing predictable reimbursement for ECG telemetry services. Clinical trials link remote ECG oversight to lower 30-day readmissions and faster intervention compared with in-clinic follow-up, strengthening physicians’ preference for continuous, real-time insight. IoMT architectures now route encrypted data directly into decision-support dashboards, lowering administrative overhead and speeding triage.
Miniaturization & Wearable-Patch Innovations
Advances in semiconductor design produced ECG patches consuming as little as 1.06 µW, extending battery life to weeks. Stretchable printed circuits enhance comfort and minimize motion artifacts, improving compliance during daily activities. Murata’s stretchable PCB prototypes and AliveCor’s credit-card-sized device illustrate how ultrathin form factors widen the addressable market for chronic disease management.
AI-Enabled Arrhythmia Analytics Adoption
Deep-learning frameworks now outperform rule-based algorithms in multi-class arrhythmia detection. Cardiomatics’ partnership with Biotronik speeds commercial adoption of cloud-hosted ECG interpretation engines. The FDA increasingly accepts AI-assisted submissions, though secure-by-design principles and continuous threat modeling remain mandatory.
Restraint Impact Analysis
| Restraint | (~) % Impact on CAGR Forecast | Geographic Relevance | Impact Timeline |
|---|---|---|---|
| High device & data-service costs | -1.4% | Global, with higher impact in emerging markets | Short term (≤ 2 years) |
| Fragmented global reimbursement in emerging markets | -1.1% | Asia-Pacific, South America, Middle East & Africa | Medium term (2-4 years) |
| Cyber-security & data-privacy compliance burden (under-reported) | -0.8% | Global, with strictest requirements in North America & Europe | Medium term (2-4 years) |
| Chip-supply volatility affecting production lead-times (under-reported) | -0.6% | Global, with highest impact on Asia-Pacific manufacturing | Short term (≤ 2 years) |
| Source: Mordor Intelligence | |||
High Device & Data-Service Costs
Procurement budgets face pressure from tariff-driven component inflation, with proposed duties affecting roughly 75% of ECG hardware imported into the United States. Fragmented reimbursement in emerging economies further constrains adoption, as payers seldom cover long monitoring durations. Supply chain bottlenecks and chip shortages elevate BOM costs, squeezing margins for both OEMs and service providers. Smaller hospitals delay replacement cycles or opt for refurbished units, dampening near-term revenue until pricing normalizes or local production scales.
Cybersecurity & Data-Privacy Compliance Burden
Section 524B obliges manufacturers to furnish Software Bills of Materials, threat models, and ongoing vulnerability management at submission and throughout a device’s life cycle. Europe’s GDPR and new state-level U.S. privacy statutes layer additional administrative overhead. Recent FDA safety notices on legacy monitors underscore financial risk for vendors lacking robust patching protocols. Smaller firms must invest heavily in secure-by-design engineering or partner with larger players, which can lengthen product launch timelines and raise total development expense.
Segment Analysis
By Product Type: Mobile Telemetry Drives Innovation
The ECG telemetry devices market size for Holter monitors stood at USD 2.28 billion in 2025, equating to 34.78% of total revenue. Mobile telemetry, while smaller, is projected to deliver the highest 6.89% CAGR, reflecting clinician demand for real-time alerts and patient-friendly wearables. Hospitals still rely on Holters for reimbursed diagnostics, but shifting preference toward automated cloud analytics accelerates mobile uptake. Implantable loop recorders serve niche long-term cases, whereas ECG management platforms facilitate data harmonization across device fleets. Competitive intensity escalates as AliveCor, HeartBeam, and Icentia secure successive FDA clearances between 2024 and 2025, underscoring the expanding innovation pipeline .
Manufacturers embed AI across every product tier, transitioning analytics from differentiator to baseline expectation. Service-oriented models bundle hardware, cloud dashboards, and clinical interpretation, solidifying recurring revenue streams. Consolidation, evidenced by Boston Scientific’s Cortex AFib buyout and PaceMate’s acquisition of Paceart Optima, aims to assemble end-to-end cardiac care portfolios. Holter incumbency thus faces dual pressure from mobile telemetry’s growth and platform-centric competitors re-defining value beyond raw hardware.
Note: Segment shares of all individual segments available upon report purchase
By Lead Type: 12-Lead Systems Gain Clinical Acceptance
Single-lead wearables captured the highest ECG telemetry devices market share at 41.56% in 2024, favored for low cost and ease of self-application. In contrast, 12-lead devices clock a 7.12% CAGR as clinicians prioritize diagnostic depth for ischemia and complex arrhythmias. QT Medical’s pediatric-focused home system exemplifies how advanced lead arrays migrate outside hospitals.
Growth in 3-6 lead monitors remains steady, bridging affordability and expanded information capture. Vendors streamline electrode placement guides and integrate AI-assisted signal quality checks. Longer wear durations and secure cloud upload pathways foster greater physician confidence in remote multi-lead studies. Overall, rising clinical value coupled with patient familiarity positions 12-lead adoption to outpace lower-lead options in high-acuity settings.
By End User: Diagnostic Centers Accelerate Adoption
Hospitals and clinics represented USD 3.07 billion of 2025 sales, translating to 46.89% of the ECG telemetry devices market size. They leverage integrated EHR interfaces and advanced decision-support engines to convert continuous ECG data into actionable care plans. Diagnostic centers, however, will expand fastest at 7.45% CAGR owing to their specialized workflow efficiency and ability to serve referring physicians with cost-effective telemetry packages.
Home healthcare demand jumps as expanded RPM codes unlock fresh reimbursement, particularly for Rural Health Clinics newly permitted to bill remote services. Ambulatory surgical centers apply telemetry to perioperative monitoring, reducing postoperative cardiac event risk. Niche users—sports medicine, occupational health, and veterinary practices—adopt lighter devices with tailored analytics, further diversifying revenue channels.
Note: Segment shares of all individual segments available upon report purchase
Geography Analysis
North America contributed 44.23% of 2024 global revenue, anchored by robust Medicare and private-insurance coverage for RPM services. Enhanced 2025 CPT codes improve rural access and incentivize longer monitoring episodes, sustaining steady upgrades across provider networks. Academic medical centers also spearhead AI validation studies, reinforcing clinical confidence in advanced analytics.
Asia-Pacific records the highest 7.32% CAGR through 2030 as China invests heavily in cardiac care infrastructure and local manufacturing; India benefits from GE Healthcare’s expanded plant capacity; and Japan approves iRhythm’s platform, showcasing receptive regulatory climates[2]Source: iRhythm Technologies, “Japan Regulatory Approval Announcement,” DiCardiology.com . Rising disposable income and heightened public health campaigns further widen adoption among middle-income groups.
Europe grows consistently as MDR compliance harmonizes quality standards and GDPR aligns with U.S. security mandates, enabling smoother multi-region launches. Partnerships such as Cardiomatics-Biotronik illustrate collaborative momentum around AI software. South America and the Middle East & Africa trail yet present long-term upside once reimbursement and distribution hurdles subside, with Brazil and GCC countries leading early procurement programs.
Competitive Landscape
Industry concentration is moderate, with the top five suppliers controlling more than half of 2024 revenue. Boston Scientific’s Cortex AFib acquisition and PaceMate’s absorption of Paceart Optima fortify vertical integration strategies. iRhythm expands geographically while defending share through proprietary analytics and turnkey service bundles. ZOLL debuts remote-view features on its X Series defibrillator, signaling a push to pair acute rescue equipment with continuous out-of-hospital telemetry .
Competition now revolves around algorithm accuracy, cybersecurity assurance, and cloud interoperability rather than raw ECG capture hardware. New entrants leverage AI virtuosity but must navigate rigorous Section 524B documentation demands, creating higher entry barriers. Pediatric, veterinary, and research niches offer white-space opportunities for focused innovators, yet overall success increasingly relies on holistic platforms that unify device fleets, analytics, and reimbursement-ready service layers.
ECG Telemetry Devices Industry Leaders
-
Nihon Kohden Corporation
-
Hill-Rom Services Inc. (Welch Allyn)
-
GE Healthcare (GE Company)
-
Koninklijke Philips NV
-
Mindray Medical International Ltd
- *Disclaimer: Major Players sorted in no particular order
Recent Industry Developments
- March 2025: iRhythm Technologies announced results from two large real-world retrospective analyses demonstrating superior arrhythmia detection benefits of long-term continuous monitoring compared to traditional short-term monitoring approaches, supporting clinical evidence for extended telemetry applications
- December 2024: HeartBeam Inc. received FDA clearance for its 12-lead ECG system designed for ambulatory monitoring, enabling comprehensive cardiac assessment outside traditional clinical settings
Global ECG Telemetry Devices Market Report Scope
As per the scope of the report, ECG telemetry devices are devices used in the monitoring of electrical activities of the heart. These devices help in the detection of electrical impulses generated by cardiac tissues, which are then translated into waveforms. The market is segmented by product (event monitoring and mobile cardiac telemetry, implantable loop recorder, and other products), application (arrhythmias, myocardial ischemia and infarction, pacemaker monitoring, and other applications), and geography (North America, Europe, Asia-Pacific, Middle East and Africa, and South America). The report also covers the estimated market sizes and trends for 17 different countries across major regions globally. The market sizes and forecasts are provided in terms of value (USD million) for all the above segments.
| Holter Monitors |
| Mobile Cardiac Telemetry |
| Implantable Loop Recorders |
| ECG Management Systems |
| Other ECG Telemetry Devices |
| Single-lead |
| 3–6 lead |
| 12-lead |
| Other Leads |
| Hospitals & Clinics |
| Diagnostic Centres |
| Home Healthcare |
| Ambulatory Surgical Centres |
| Others |
| North America | United States |
| Canada | |
| Mexico | |
| Europe | Germany |
| United Kingdom | |
| France | |
| Italy | |
| Spain | |
| Rest of Europe | |
| Asia-Pacific | China |
| India | |
| Japan | |
| South Korea | |
| Australia | |
| Rest of Asia-Pacific | |
| South America | Brazil |
| Argentina | |
| Rest of South America | |
| Middle East and Africa | GCC |
| South Africa | |
| Rest of Middle East and Africa |
| By Product Type (Value) | Holter Monitors | |
| Mobile Cardiac Telemetry | ||
| Implantable Loop Recorders | ||
| ECG Management Systems | ||
| Other ECG Telemetry Devices | ||
| By Lead Type (Value) | Single-lead | |
| 3–6 lead | ||
| 12-lead | ||
| Other Leads | ||
| By End User (Value) | Hospitals & Clinics | |
| Diagnostic Centres | ||
| Home Healthcare | ||
| Ambulatory Surgical Centres | ||
| Others | ||
| By Geography (Value) | North America | United States |
| Canada | ||
| Mexico | ||
| Europe | Germany | |
| United Kingdom | ||
| France | ||
| Italy | ||
| Spain | ||
| Rest of Europe | ||
| Asia-Pacific | China | |
| India | ||
| Japan | ||
| South Korea | ||
| Australia | ||
| Rest of Asia-Pacific | ||
| South America | Brazil | |
| Argentina | ||
| Rest of South America | ||
| Middle East and Africa | GCC | |
| South Africa | ||
| Rest of Middle East and Africa | ||
Key Questions Answered in the Report
What is the forecasted value of the ECG telemetry devices market by 2030?
It is projected to reach USD 8.92 billion, reflecting a 6.37% CAGR from 2025.
Which product category is growing fastest?
Mobile cardiac telemetry is set to expand at a 6.89% CAGR through 2030 due to real-time monitoring benefits.
How are new CPT codes influencing adoption?
Enhanced 2025 RPM codes (99453-99458) allow broader billing, especially for Rural Health Clinics, driving uptake in underserved areas.
Why are 12-lead systems gaining traction?
Clinicians favor their comprehensive diagnostic capability for ischemia and complex arrhythmias, resulting in a 7.12% CAGR through 2030.
What security requirements affect device approval?
Section 524B mandates Software Bills of Materials, threat modeling, and ongoing vulnerability management for all connected devices.
Which region offers the strongest growth outlook?
Asia-Pacific leads with a 7.32% CAGR as healthcare access broadens and regulatory bodies accelerate approvals.
Page last updated on:
